Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 105

    1.

    A Long-term Follow-up of Serum Myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Patients with Graves Disease Treated with Propylthiouracil.

    Ishii R, Imaizumi M, Ide A, Sera N, Ueki I, Horie I, Ando T, Usa T, Ejima E, Ashizawa K, Eguchi K.

    Endocr J. 2009 Oct 23. [Epub ahead of print]PMID: 19851036 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Outcome following removal of canine spindle cell tumours in first opinion practice: 104 cases.

    Chase D, Bray J, Ide A, Polton G.

    J Small Anim Pract. 2009 Nov;50(11):568-74. Epub 2009 Oct 8.PMID: 19814769 [PubMed - in process]Related articles

    3.

    Chronic electrical stimulation of cultured hippocampal networks increases spontaneous spike rates.

    Brewer GJ, Boehler MD, Ide AN, Wheeler BC.

    J Neurosci Methods. 2009 Oct 30;184(1):104-9. Epub 2009 Aug 8.PMID: 19666055 [PubMed - in process]Related articles

    4.

    Mass spectrometric investigation and formation mechanisms of high-mass species in the downstream region of Ar/CF(4)/O(2) plasmas.

    Furuya K, Ide A, Okumura H, Harata A.

    Phys Chem Chem Phys. 2009 Feb 14;11(6):934-42. Epub 2008 Dec 11.PMID: 19177211 [PubMed]Related articles

    5.

    Neuron network activity scales exponentially with synapse density.

    Brewer GJ, Boehler MD, Pearson RA, DeMaris AA, Ide AN, Wheeler BC.

    J Neural Eng. 2009 Feb;6(1):014001. Epub 2008 Dec 22.PMID: 19104141 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin.

    Nakamura T, Kotani M, Tonozuka T, Ide A, Oguma K, Nishikawa A.

    J Mol Biol. 2009 Jan 30;385(4):1193-206. Epub 2008 Nov 27.PMID: 19071137 [PubMed - indexed for MEDLINE]Related articles

    7.

    Tunable porosity in bridged organosilicas using self-organizing precursors.

    Ide A, Scholz G, Thomas A.

    Langmuir. 2008 Nov 4;24(21):12539-46. Epub 2008 Sep 30.PMID: 18823136 [PubMed]Related articles

    8.

    Effects of inhaled monoethanolamine on bronchoconstriction.

    Kamijo Y, Hayashi I, Ide A, Yoshimura K, Soma K, Majima M.

    J Appl Toxicol. 2009 Jan;29(1):15-9.PMID: 18651722 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sugar-binding sites of the HA1 subcomponent of Clostridium botulinum type C progenitor toxin.

    Nakamura T, Tonozuka T, Ide A, Yuzawa T, Oguma K, Nishikawa A.

    J Mol Biol. 2008 Feb 22;376(3):854-67. Epub 2007 Dec 23.PMID: 18178224 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model.

    Iwanami J, Mogi M, Okamoto S, Gao XY, Li JM, Min LJ, Ide A, Tsukuda K, Iwai M, Horiuchi M.

    Eur J Pharmacol. 2007 Jul 2;566(1-3):153-9. Epub 2007 Mar 31.PMID: 17475237 [PubMed - indexed for MEDLINE]Related articles

    12.

    Gastric stenosis in severe corrosive gastritis: prognostic evaluation by endoscopic ultrasonography.

    Kamijo Y, Kondo I, Watanabe M, Kan'o T, Ide A, Soma K.

    Clin Toxicol (Phila). 2007;45(3):284-6.PMID: 17453882 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Case of amoxapine-induced refractory status epilepticus which was successfully treated with propofol]

    Ide A.

    Chudoku Kenkyu. 2006 Oct;19(4):407-8. Japanese. No abstract available. PMID: 17133983 [PubMed - indexed for MEDLINE]Related articles

    14.

    Enantioselective equilibration-access to chiral aldol adducts of mandelic acid esters.

    Scholtis S, Ide A, Mahrwald R.

    Org Lett. 2006 Nov 9;8(23):5353-5.PMID: 17078716 [PubMed]Related articles

    15.

    Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice.

    Mogi M, Iwai M, Chen R, Iwanami J, Ide A, Tsukuda K, Yoshii T, Horiuchi M.

    Am J Hypertens. 2006 Nov;19(11):1144-9.PMID: 17070425 [PubMed - indexed for MEDLINE]Related articles

    16.

    Extreme genetic risk for type 1A diabetes.

    Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS.

    Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14074-9. Epub 2006 Sep 11.PMID: 16966600 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.

    Iwai M, Chen R, Ide A, Iwanami J, Tomochika H, Tomono Y, Mogi M, Horiuchi M.

    J Hypertens. 2006 Oct;24(10):2023-31.PMID: 16957563 [PubMed - indexed for MEDLINE]Related articles

    18.

    Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.

    Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M.

    Hypertens Res. 2006 Jun;29(6):457-66.PMID: 16940709 [PubMed - indexed for MEDLINE]Related articles

    19.

    Attenuation of inflammatory vascular remodeling by angiotensin II type 1 receptor-associated protein.

    Oshita A, Iwai M, Chen R, Ide A, Okumura M, Fukunaga S, Yoshii T, Mogi M, Higaki J, Horiuchi M.

    Hypertension. 2006 Oct;48(4):671-6. Epub 2006 Aug 21.PMID: 16923992 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Peripheral T-cell lymphoma of the eyelid.

    Mito H, Kakizaki H, Tsuji H, Ide A, Takeuchi K, Takamura H.

    Jpn J Ophthalmol. 2006 Jul-Aug;50(4):388-90. No abstract available. PMID: 16897229 [PubMed - indexed for MEDLINE]Related articles

    21.

    Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.

    Hamai M, Iwai M, Ide A, Tomochika H, Tomono Y, Mogi M, Horiuchi M.

    Neuropharmacology. 2006 Sep;51(4):822-8. Epub 2006 Jul 7.PMID: 16824557 [PubMed - indexed for MEDLINE]Related articles

    22.

    Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype.

    Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR.

    Diabetes. 2006 May;55(5):1265-9.PMID: 16644681 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Mixed venous oxygen saturation monitoring in calcium channel blocker poisoning: tissue hypoxia avoidance despite hypotension.

    Kamijo Y, Yoshida T, Ide A, Soma K.

    Am J Emerg Med. 2006 May;24(3):357-60. No abstract available. PMID: 16635715 [PubMed - indexed for MEDLINE]Related articles

    24.

    Role of angiotensin II receptor subtypes in conjunctival wound healing.

    Mizoue S, Iwai M, Ide A, Suzuki J, Horiuchi M, Shiraishi A, Ohashi Y.

    Curr Eye Res. 2006 Feb;31(2):129-36.PMID: 16500763 [PubMed - indexed for MEDLINE]Related articles

    25.

    Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.

    Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ.

    J Autoimmun. 2005;25 Suppl:40-5. Epub 2005 Oct 19. Review.PMID: 16242305 [PubMed - indexed for MEDLINE]Related articles

    26.

    Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.

    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.

    Circulation. 2005 Sep 13;112(11):1636-43. Epub 2005 Sep 6.PMID: 16145000 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.

    Ide A, Babu SR, Robles DT, Wang T, Erlich HA, Bugawan TL, Rewers M, Fain PR, Eisenbarth GS.

    J Clin Immunol. 2005 Jul;25(4):303-8.PMID: 16133985 [PubMed - indexed for MEDLINE]Related articles

    28.

    Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression.

    Okumura M, Iwai M, Ide A, Mogi M, Ito M, Horiuchi M.

    Hypertension. 2005 Sep;46(3):577-83. Epub 2005 Aug 15.PMID: 16103268 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

    Suzuki J, Iwai M, Li Z, Li JM, Min LJ, Ide A, Yoshii T, Oshita A, Mogi M, Horiuchi M.

    J Hypertens. 2005 Jul;23(7):1383-9.PMID: 15942461 [PubMed - indexed for MEDLINE]Related articles

    30.

    "Extended" A1, B8, DR3 haplotype shows remarkable linkage disequilibrium but is similar to nonextended haplotypes in terms of diabetes risk.

    Ide A, Babu SR, Robles DT, Wang T, Erlich HA, Bugawan TL, Rewers M, Fain PR, Eisenbarth GS.

    Diabetes. 2005 Jun;54(6):1879-83.PMID: 15919812 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.

    Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H, Horiuchi M.

    Hypertension. 2005 Apr;45(4):545-51. Epub 2005 Feb 21.PMID: 15723967 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Stromal cell-derived factor-1 chemokine gene variant in patients with type 1 diabetes and autoimmune thyroid disease.

    Kawasaki E, Ide A, Abiru N, Kobayashi M, Fukushima T, Kuwahara H, Kita A, Uotani S, Yamasaki H, Eguchi K.

    Ann N Y Acad Sci. 2004 Dec;1037:79-83.PMID: 15699497 [PubMed - indexed for MEDLINE]Related articles

    33.

    Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.

    MacDougall CA, Vargas M, Soares CR, Holzer RG, Ide AE, Jorcyk CL.

    Prostate. 2005 Jul 1;64(2):139-48.PMID: 15678502 [PubMed - indexed for MEDLINE]Related articles

    34.

    Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population.

    Barker JM, Ide A, Hostetler C, Yu L, Miao D, Fain PR, Eisenbarth GS, Gottlieb PA.

    J Clin Endocrinol Metab. 2005 Jan;90(1):128-34. Epub 2004 Oct 13.PMID: 15483092 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.

    Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, Sakanaka M, Shiuchi T, Horiuchi M.

    Circulation. 2004 Aug 17;110(7):843-8. Epub 2004 Aug 2.PMID: 15289370 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Causes of undercorrection of medial palpebral fissures in blepharoptosis surgery.

    Kakizaki H, Zako M, Ide A, Mito H, Nakano T, Iwaki M.

    Ophthal Plast Reconstr Surg. 2004 May;20(3):198-201.PMID: 15167726 [PubMed - indexed for MEDLINE]Related articles

    37.

    Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes.

    Paronen J, Liu E, Moriyama H, Devendra D, Ide A, Taylor R, Yu L, Miao D, Melanitou E, Eisenbarth GS.

    J Autoimmun. 2004 Jun;22(4):307-13.PMID: 15120754 [PubMed - indexed for MEDLINE]Related articles

    38.

    Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes.

    Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, Fukushima T, Takahashi R, Kuwahara H, Kita A, Oshima K, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K.

    J Autoimmun. 2004 Feb;22(1):73-8.PMID: 14709415 [PubMed - indexed for MEDLINE]Related articles

    39.

    Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes.

    Kawasaki E, Abiru N, Ide A, Sun F, Fukushima T, Takahashi R, Kuwahara H, Fujita N, Kita A, Oshima K, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K.

    Ann N Y Acad Sci. 2003 Nov;1005:440-8.PMID: 14679108 [PubMed - indexed for MEDLINE]Related articles

    40.

    Association of interleukin-18 gene promoter polymorphisms in type 1 diabetes and autoimmune thyroid disease.

    Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Ishii R, Takahashi R, Kuwahara H, Fujita N, Kita A, Imaizumi M, Oshima K, Usa T, Uotani S, Ejima E, Yamasaki H, Ashizawa K, Yamaguchi Y, Eguchi K.

    Ann N Y Acad Sci. 2003 Nov;1005:436-9.PMID: 14679107 [PubMed - indexed for MEDLINE]Related articles

    41.

    Interleukin-10 gene promoter region polymorphisms in patients with type 1 diabetes and autoimmune thyroid disease.

    Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Ishii R, Takahashi R, Kuwahara H, Fujita N, Kita A, Imaizumi M, Oshima K, Usa T, Uotani S, Ejima E, Yamasaki H, Ashizawa K, Yamaguchi Y, Eguchi K.

    Ann N Y Acad Sci. 2003 Nov;1005:344-7.PMID: 14679088 [PubMed - indexed for MEDLINE]Related articles

    42.

    Correlation between interleukin 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjögren's syndrome.

    Origuchi T, Kawasaki E, Ide A, Kamachi M, Tanaka F, Ida H, Kawakami A, Migita K, Eguchi K.

    Ann Rheum Dis. 2003 Nov;62(11):1117-8. No abstract available. PMID: 14583579 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population.

    Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Takahashi R, Kuwahara H, Fujita N, Kita A, Oshima K, Uotani S, Yamasaki H, Yamaguchi Y, Kawabata Y, Fujisawa T, Ikegami H, Eguchi K.

    Hum Immunol. 2003 Oct;64(10):973-8.PMID: 14522095 [PubMed - indexed for MEDLINE]Related articles

    44.

    Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.

    Ide A, Eisenbarth GS.

    Rev Endocr Metab Disord. 2003 Sep;4(3):243-53. Review. No abstract available. PMID: 14501175 [PubMed - indexed for MEDLINE]Related articles

    45.

    Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset.

    Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H, Fujita N, Kita A, Oshima K, Sakamaki H, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K.

    Hum Immunol. 2002 Aug;63(8):690-5.PMID: 12121678 [PubMed - indexed for MEDLINE]Related articles

    46.

    Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.

    Ide A, Ashizawa K, Ishikawa N, Ishii R, Ando T, Abe Y, Sera N, Usa T, Tominaga T, Ejima E, Nakashima M, Ito K, Ito K, Eguchi K.

    Thyroid. 2001 Nov;11(11):1055-61.PMID: 11762716 [PubMed - indexed for MEDLINE]Related articles

    47.

    Pulmonary nocardiosis associated with idiopathic thrombocytopenic purpura.

    Ando T, Usa T, Ide A, Abe Y, Sera N, Tominaga T, Ejima E, Ashizawa K, Nakata K, Eguchi K.

    Intern Med. 2001 Mar;40(3):246-9.PMID: 11310493 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    A sex difference in the postcentral sulcus of the human brain.

    Ide A, Aboitiz F.

    Brain Res. 2001 Feb 2;890(2):330-2.PMID: 11164799 [PubMed - indexed for MEDLINE]Related articles

    49.

    Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (131I) therapy.

    Sera N, Ashizawa K, Ando T, Ide A, Abe Y, Usa T, Tominaga T, Ejima E, Hayashi T, Shimokawa I, Eguchi K.

    Thyroid. 2000 Nov;10(11):975-9.PMID: 11128725 [PubMed - indexed for MEDLINE]Related articles

    50.

    Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells.

    Abe Y, Kawakami A, Nakashima T, Ejima E, Fujiyama K, Kiriyama T, Ide A, Sera N, Usa T, Tominaga T, Ashizawa K, Yokoyama N, Eguchi K.

    J Lab Clin Med. 2000 Nov;136(5):344-54.PMID: 11079461 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...